Confirmatory phase 3 trials seem to be not uncommon. Most recently PAR was advised by the FDA that they would need to have 2 phase 3 trials for their PPS drug. They approached the FDA wanting to use confirmatory data but were forced to undertake a capital raising for a confirmatory phase 3 trial that they will be running concurrently with the first phase 3 trial.
Confirmatory phase 3 trials seem to be not uncommon. Most...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |